INLET STRATEGIES

Lobbying for COHERUS BIOSCIENCES, INC · pharmaceutical development

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $45,000.00 income · posted Jul 14, 2025

Lobbying activity 2

Health Issues

Issues related to domestic manufacturing of pharmaceuticals

Medicare/Medicaid

Issues related to the federal governments procurement of Udenyca

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.